Eptifibatide vs primary intervention | No demonstrated result suggested Initial TIMI 3 flow by 233% (not demonstrated) | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Initial TIMI 3 flow | 3.33 [1.12 9.86] | p=0.04 | 0 | 102 | 1 | INTAMI (Zeymer), | Final TIMI 3 flow | 1.04 [0.35 3.14] | p=1.00 | 0 | 99 | 1 | INTAMI (Zeymer), | urgent target vessel revascularisation | 1.85 [0.16 21.06] | p=1.00 | 0 | 102 | 1 | INTAMI (Zeymer), | Non fatal MI | 6.47 [0.33 128.64] | p=1.00 | 0 | 102 | 1 | INTAMI (Zeymer), | All cause death | 0.92 [0.13 6.83] | p=1.00 | 0 | 102 | 1 | INTAMI (Zeymer), | Major bleeding | 0.92 [0.13 6.83] | p=1.00 | 0 | 102 | 1 | INTAMI (Zeymer), | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |